Responses
Regular and young investigator award abstracts
Checkpoint blockade therapy
252 Immune-related adverse events associated with immune checkpoint inhibitor therapy are associated with enhanced survival and disease-specific incidence
Compose a Response to This Article
Other responses
No responses have been published for this article.
